Premium
Frontispiece: Catalytic Asymmetric Synthesis of the anti‐COVID‐19 Drug Remdesivir
Author(s) -
Wang Mo,
Zhang Lu,
Huo Xiaohong,
Zhang Zhenfeng,
Yuan Qianjia,
Li Panpan,
Chen Jianzhong,
Zou Yashi,
Wu Zhengxing,
Zhang Wanbin
Publication year - 2020
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202084761
Subject(s) - covid-19 , publishing , chemistry , scientific publishing , prime (order theory) , combinatorial chemistry , nanotechnology , political science , virology , medicine , materials science , disease , outbreak , infectious disease (medical specialty) , mathematics , pathology , combinatorics , law
Asymmetric Synthesis The first catalytic asymmetric synthesis of remdesivir by the coupling of the P‐racemic phosphoryl chloride with protected nucleoside GS441524 is described by W. Zhang et al. in their Communication on page 20814.